FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134855990> ?p ?o ?g. }

• W2134855990 endingPage "IN6" @default.
• W2134855990 startingPage "690" @default.
• W2134855990 abstract "PURPOSE: The factors preventing the translation of preclinical findings supporting the clinical development mTOR-targeted therapy in pancreatic cancer therapy remain undetermined. Stromal cell.derived factor 1α (SDF-1α)-CXCR4 signaling was examined as a representative microenvironmental factor able to promote mTOR-targeted therapy resistance in pancreatic cancer. EXPERIMENTAL DESIGN: Primary pancreas explant xenografts and in vitro experiments were used to perform pharmacodynamic analyses of SDF-1α-CXCR4 regulation of the mTOR pathway. Combinatorial effects of CXCR4, EGFR, and mTOR pharmacologic inhibition were evaluated in temsirolimus-resistant and -sensitive xenografts. Intratumoral gene and protein expressions of mTOR pathway effectors cyclin D1, c-Myc, and VEGF were evaluated. RESULTS: Baseline intratumoral SDF-1α gene expression correlated with temsirolimus resistance in explant models. SDF-1α stimulation of pancreatic cells resulted in CXCR4-mediated PI3-kinase-dependent S6-RP phosphorylation (pS6-RP) on exposure to temsirolimus. Combinatorial therapy with AMD3465 (CXCR4 small-molecule inhibitor) and temsirolimus resulted in effective tumor growth inhibition to overcome temsirolimus resistance. In contrast, SDF-1α exposure induced a temsirolimus-resistant phenotype in temsirolimus-sensitive explants. AMD3465 inhibited CXCR4-mediated intratumoral S6-RP phosphorylation and cyclin D and c-myc gene expression. Next, CXCR4 promoted intratumoral EGFR expression in association with temsirolimus resistance. Treatment with AMD3465, temsirolimus- and erlotinib-mediated tumor growth inhibition to overcome temsirolimus resistance in the explant model. Lastly, SDF-1α-CXCR4 signaling increased intratumoral VEGF gene and protein expression. CONCLUSIONS: SDF-1α-CXCR4 signaling represents a microenvironmental factor that can maintain mTOR pathway fidelity to promote resistance to mTOR-targeted therapy in pancreatic cancer by a variety of mechanisms such as recruitment of EGFR signaling and angiogenesis." @default.
• W2134855990 created "2016-06-24" @default.
• W2134855990 creator A5009183159 @default.
• W2134855990 creator A5010738960 @default.
• W2134855990 creator A5017739964 @default.
• W2134855990 creator A5026482426 @default.
• W2134855990 creator A5029296725 @default.
• W2134855990 creator A5061712316 @default.
• W2134855990 creator A5078259926 @default.
• W2134855990 creator A5083575921 @default.
• W2134855990 creator A5086504706 @default.
• W2134855990 creator A5086660695 @default.
• W2134855990 date "2012-08-01" @default.
• W2134855990 modified "2023-10-18" @default.
• W2134855990 title "Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer" @default.
• W2134855990 cites W1931508686 @default.
• W2134855990 cites W1964064067 @default.
• W2134855990 cites W1978796256 @default.
• W2134855990 cites W1980451446 @default.
• W2134855990 cites W1981149366 @default.
• W2134855990 cites W1998971866 @default.
• W2134855990 cites W2013661099 @default.
• W2134855990 cites W2015062933 @default.
• W2134855990 cites W2015173256 @default.
• W2134855990 cites W2022979958 @default.
• W2134855990 cites W2026890779 @default.
• W2134855990 cites W2029443168 @default.
• W2134855990 cites W2066135299 @default.
• W2134855990 cites W2073963371 @default.
• W2134855990 cites W2075678923 @default.
• W2134855990 cites W2080196370 @default.
• W2134855990 cites W2081711123 @default.
• W2134855990 cites W2082180864 @default.
• W2134855990 cites W2083452953 @default.
• W2134855990 cites W2083612980 @default.
• W2134855990 cites W2085154844 @default.
• W2134855990 cites W2101037339 @default.
• W2134855990 cites W2107441200 @default.
• W2134855990 cites W2117105709 @default.
• W2134855990 cites W2121557366 @default.
• W2134855990 cites W2124587511 @default.
• W2134855990 cites W2128095147 @default.
• W2134855990 cites W2131170195 @default.
• W2134855990 cites W2138155367 @default.
• W2134855990 cites W2141419529 @default.
• W2134855990 cites W2144025124 @default.
• W2134855990 cites W2147483024 @default.
• W2134855990 cites W2154108823 @default.
• W2134855990 cites W2155191802 @default.
• W2134855990 cites W2156323704 @default.
• W2134855990 cites W2156411980 @default.
• W2134855990 cites W2158134441 @default.
• W2134855990 cites W2161199652 @default.
• W2134855990 cites W2164034599 @default.
• W2134855990 cites W2165705217 @default.
• W2134855990 cites W2168207107 @default.
• W2134855990 cites W2172077519 @default.
• W2134855990 doi "https://doi.org/10.1593/neo.111810" @default.
• W2134855990 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3432475" @default.
• W2134855990 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22952422" @default.
• W2134855990 hasPublicationYear "2012" @default.
• W2134855990 type Work @default.
• W2134855990 sameAs 2134855990 @default.
• W2134855990 citedByCount "45" @default.
• W2134855990 countsByYear W21348559902012 @default.
• W2134855990 countsByYear W21348559902013 @default.
• W2134855990 countsByYear W21348559902014 @default.
• W2134855990 countsByYear W21348559902015 @default.
• W2134855990 countsByYear W21348559902016 @default.
• W2134855990 countsByYear W21348559902017 @default.
• W2134855990 countsByYear W21348559902018 @default.
• W2134855990 countsByYear W21348559902019 @default.
• W2134855990 countsByYear W21348559902020 @default.
• W2134855990 countsByYear W21348559902021 @default.
• W2134855990 countsByYear W21348559902022 @default.
• W2134855990 countsByYear W21348559902023 @default.
• W2134855990 crossrefType "journal-article" @default.
• W2134855990 hasAuthorship W2134855990A5009183159 @default.
• W2134855990 hasAuthorship W2134855990A5010738960 @default.
• W2134855990 hasAuthorship W2134855990A5017739964 @default.
• W2134855990 hasAuthorship W2134855990A5026482426 @default.
• W2134855990 hasAuthorship W2134855990A5029296725 @default.
• W2134855990 hasAuthorship W2134855990A5061712316 @default.
• W2134855990 hasAuthorship W2134855990A5078259926 @default.
• W2134855990 hasAuthorship W2134855990A5083575921 @default.
• W2134855990 hasAuthorship W2134855990A5086504706 @default.
• W2134855990 hasAuthorship W2134855990A5086660695 @default.
• W2134855990 hasBestOaLocation W21348559901 @default.
• W2134855990 hasConcept C121608353 @default.
• W2134855990 hasConcept C126322002 @default.
• W2134855990 hasConcept C129470790 @default.
• W2134855990 hasConcept C13373296 @default.
• W2134855990 hasConcept C16930146 @default.
• W2134855990 hasConcept C183713625 @default.
• W2134855990 hasConcept C203014093 @default.
• W2134855990 hasConcept C2776820818 @default.
• W2134855990 hasConcept C2780210213 @default.
• W2134855990 hasConcept C502942594 @default.

• next